306 related articles for article (PubMed ID: 2677436)
1. [Clinical significance of cross linked fibrin degradation products in thrombotic disorders].
Koyama T; Oura Y; Higuchi M; Kakishita E; Nagai K
Rinsho Ketsueki; 1989 May; 30(5):659-62. PubMed ID: 2677436
[TBL] [Abstract][Full Text] [Related]
2. Fibrin D-dimer in thrombogenic disorders.
Matsuo T; Kobayashi H; Kario K; Suzuki S
Semin Thromb Hemost; 2000; 26(1):101-7. PubMed ID: 10805290
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of clinical usefulness of a rapid quantitative measurement of D dimer (cross-linked fibrin degradation products)].
Takahashi H; Wada K; Takizawa S; Sakurai G; Hanano M; Niwano H; Tatewaki W; Shibata A
Rinsho Ketsueki; 1991 Dec; 32(12):1533-9. PubMed ID: 1779452
[TBL] [Abstract][Full Text] [Related]
4. [Changes in molecular markers in patients with thrombotic thrombocytopenic purpura].
Takamatsu J
Nihon Rinsho; 1993 Jan; 51(1):135-7. PubMed ID: 8433505
[TBL] [Abstract][Full Text] [Related]
5. Thrombotic thrombocytopenic purpura: a syndrome of intravascular platelet consumption.
Neame PB; Hirsh J; Browman G; Denburg J; D'Souza TJ; Gallus A; Brain MC
Can Med Assoc J; 1976 Jun; 114(12):1108-12. PubMed ID: 1084215
[TBL] [Abstract][Full Text] [Related]
6. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
Koga S
Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
[TBL] [Abstract][Full Text] [Related]
7. [The significance of the levels of D-dimer in thrombotic conditions].
Roul C; Aillaud MF; Elias A; Bouvier JL; Serradimigni A; Juhan-Vague I
Ann Biol Clin (Paris); 1988; 46(9):730-3. PubMed ID: 2851949
[TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of whole blood D-dimer test to plasma D-dimer test for diagnosis of disseminated intravascular coagulation.
Gupta PK; Gupta M; Chatterjee T; Saxena R
Indian J Exp Biol; 2005 Apr; 43(4):382-4. PubMed ID: 15875726
[TBL] [Abstract][Full Text] [Related]
9. D-dimer assays in diagnosis and management of thrombotic and bleeding disorders.
Bates SM
Semin Thromb Hemost; 2012 Oct; 38(7):673-82. PubMed ID: 23041982
[TBL] [Abstract][Full Text] [Related]
10. Measurement of crosslinked fibrin degradation products - an immunoassay using monoclonal antibodies.
Elms MJ; Bunce IH; Bundesen PG; Rylatt DB; Webber AJ; Masci PP; Whitaker AN
Thromb Haemost; 1983 Aug; 50(2):591-4. PubMed ID: 6356456
[TBL] [Abstract][Full Text] [Related]
11. Fibrin degradation products, fibrin monomer and soluble fibrin in disseminated intravascular coagulation.
Horan JT; Francis CW
Semin Thromb Hemost; 2001 Dec; 27(6):657-66. PubMed ID: 11740689
[TBL] [Abstract][Full Text] [Related]
12. Incidence and clinical significance of elevated fibrin(ogen) degradation product and/or D-dimer levels in liver cirrhosis patients.
Cioni G; Cristani A; Mussini C; Grandi S; Pentore R; Zeneroli ML; Tizzanini W; Zagni G; Ventura E
Ital J Gastroenterol; 1990 Apr; 22(2):70-4. PubMed ID: 2131934
[TBL] [Abstract][Full Text] [Related]
13. [A proposed method for the laboratory diagnosis of disseminated intravascular coagulation in liver cirrhosis].
Cristani A; Cioni G; Mussini C; Pentore R; Zagni G; Ventura E
Recenti Prog Med; 1990 May; 81(5):322-4. PubMed ID: 2377810
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of a latex test for determining the fibrinogen/fibrin D-dimer (XDP)].
Barsotti A; Savarino A
Quad Sclavo Diagn; 1987 Dec; 23(4):421-4. PubMed ID: 3508302
[TBL] [Abstract][Full Text] [Related]
15. [Measurement of FDP-D-dimer in DIC and pre-DIC].
Takagi M; Wada H; Tanigawa M; Iwasaki E; Deguchi A; Mori Y; Suzuki H; Ohkubo I; Endou T; Deguchi K
Rinsho Byori; 1990 Jul; 38(7):806-12. PubMed ID: 2205744
[TBL] [Abstract][Full Text] [Related]
16. Quantification of D-dimer using a new fully automated assay: its application for the diagnosis of deep vein thrombosis.
Villa P; Ferrando F; Serra J; Faus H; Mira Y; Vayá A; Aznar J
Haematologica; 2000 May; 85(5):520-4. PubMed ID: 10800170
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of plasma D-dimer levels and serum VEGF levels in patients with hepatocellular carcinoma.
Tseng CS; Lo HW; Chen PH; Chuang WL; Juan CC; Ker CG
Hepatogastroenterology; 2004; 51(59):1454-8. PubMed ID: 15362775
[TBL] [Abstract][Full Text] [Related]
18. [The clinical value of D-dimer in the diagnosis and treatment of thromboembolic complications and DIC syndrome in cancer patients].
Madzhuga AV; Somonova OV; Elizarova AL; Sviridova SP; Zubrikhin GN
Anesteziol Reanimatol; 2005; (5):55-7. PubMed ID: 16318055
[TBL] [Abstract][Full Text] [Related]
19. A quantitative enzyme immunoassay for primary fibrinogenolysis products in plasma.
Koppert PW; Kuipers W; Hoegee-de Nobel B; Brommer EJ; Koopman J; Nieuwenhuizen W
Thromb Haemost; 1987 Feb; 57(1):25-8. PubMed ID: 2438796
[TBL] [Abstract][Full Text] [Related]
20. Limited utility of a rapid quantitative enzyme-linked fluorescent assay for the D-dimer in the diagnosis of overt disseminated intravascular coagulation.
Sharma P; Saxena R
Clin Appl Thromb Hemost; 2010 Dec; 16(6):609-13. PubMed ID: 20211928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
